Jereme M Sylvain Dexcom Inc (DXCM) insider trading activity

DXCM Quotes by TradingView

Jereme M Sylvain is EVP, Chief Financal Officer of DEXCOM INC. Currently has a direct ownership of 80,030 shares of DXCM, which is worth approximately $6.92 Million. The most recent transaction as insider was on Dec 16, 2024, when has been sold 744 shares (Common Stock) at a price of $76.87 per share, resulting in proceeds of $57,191. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80K
5.04% 3M change
7.42% 12M change
Total Value Held $6.92 Million

Jereme M Sylvain Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2024
SELL
Open market or private sale
$57,191 $76.87 p/Share
744 Reduced 0.92%
80,030 Common Stock
Nov 15 2024
SELL
Open market or private sale
$264,285 $75.51 p/Share
3,500 Reduced 4.15%
80,774 Common Stock
Sep 09 2024
SELL
Open market or private sale
$51,585 $69.15 p/Share
746 Reduced 0.88%
84,274 Common Stock
Jun 10 2024
SELL
Open market or private sale
$85,712 $115.05 p/Share
745 Reduced 0.87%
84,948 Common Stock
Mar 12 2024
SELL
Open market or private sale
$1,567,355 $134.41 p/Share
11,661 Reduced 12.0%
85,534 Common Stock
Mar 08 2024
BUY
Grant, award, or other acquisition
-
26,053 Added 21.14%
97,195 Common Stock
Feb 20 2024
SELL
Open market or private sale
$392,562 $116.73 p/Share
3,363 Reduced 4.51%
71,142 Common Stock
Jan 16 2024
SELL
Open market or private sale
$338,004 $123.63 p/Share
2,734 Reduced 3.54%
74,505 Common Stock
Jan 12 2024
BUY
Grant, award, or other acquisition
-
7,171 Added 8.5%
77,239 Common Stock
Dec 18 2023
SELL
Sale (or disposition) back to the issuer
$357,264 $121.85 p/Share
2,932 Reduced 4.02%
70,068 Common Stock
Aug 22 2023
SELL
Open market or private sale
$192,476 $104.38 p/Share
1,844 Reduced 2.47%
72,867 Common Stock
May 22 2023
SELL
Open market or private sale
$282,192 $117.58 p/Share
2,400 Reduced 3.11%
74,711 Common Stock
Mar 10 2023
SELL
Sale (or disposition) back to the issuer
$1,071,445 $111.4 p/Share
9,618 Reduced 11.09%
77,111 Common Stock
Mar 08 2023
BUY
Grant, award, or other acquisition
-
21,769 Added 20.06%
86,729 Common Stock
Feb 22 2023
SELL
Open market or private sale
$274,896 $114.54 p/Share
2,400 Reduced 3.57%
64,837 Common Stock
Nov 21 2022
SELL
Open market or private sale
$270,288 $112.62 p/Share
2,400 Reduced 3.45%
67,237 Common Stock
Jun 06 2022
SELL
Open market or private sale
$180,942 $301.57 p/Share
600 Reduced 3.33%
17,408 Common Stock
Mar 09 2022
SELL
Sale (or disposition) back to the issuer
$792,223 $406.06 p/Share
1,951 Reduced 9.78%
18,008 Common Stock
Mar 08 2022
BUY
Grant, award, or other acquisition
-
5,297 Added 20.97%
19,959 Common Stock
Mar 04 2022
SELL
Open market or private sale
$253,764 $422.94 p/Share
600 Reduced 3.93%
14,662 Common Stock
Dec 15 2021
BUY
Grant, award, or other acquisition
-
2,925 Added 16.12%
15,217 Common Stock
Dec 06 2021
SELL
Open market or private sale
$310,554 $517.59 p/Share
600 Reduced 4.65%
12,292 Common Stock
Nov 09 2021
SELL
Grant, award, or other acquisition
$402,032 $634.12 p/Share
634 Reduced 4.69%
12,892 Common Stock
Sep 09 2021
SELL
Open market or private sale
$220,415 $541.56 p/Share
407 Reduced 2.92%
13,526 Common Stock
Sep 07 2021
SELL
Open market or private sale
$320,156 $545.41 p/Share
587 Reduced 4.04%
13,933 Common Stock
JMS

Jereme M Sylvain

EVP, Chief Financal Officer
San Diego, CA

Track Institutional and Insider Activities on DXCM

Follow DEXCOM INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

News

Receive news related to DEXCOM INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DXCM